Episode Description
Experts discuss new clinical trial data and long-term safety of Janus kinase (JAK) inhibitors in alopecia areata (AA).
Credit available for this activity expires: 10/21/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/pathway-prescription-alopecia-areata-2026a10012z7?ecd=bdc_podcast_libsyn_mscpedu



























